Regarding the role of IRAK-M in cancer, studies show that tumor cells induce the expression of IRAK-M on human monocytes via CD44 and TLR4, resulting in monocyte deactivation and decreased expression of pro-inflammatory cytokines (90). This evidence concerns the gene IRAK3 and neoplasm.